- Trials with a EudraCT protocol (1,788)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (216)
1,788 result(s) found for: Metabolic Disease.
Displaying page 1 of 90.
EudraCT Number: 2016-001661-91 | Sponsor Protocol Number: ML19569 | Start Date*: 2016-12-09 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche AG | ||||||||||||||||||
Full Title: Open-label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents | ||||||||||||||||||
Medical condition: Obesity in combination with metabolic disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000565-40 | Sponsor Protocol Number: GLM101-002 | Start Date*: 2022-11-04 | |||||||||||
Sponsor Name:Glycomine, Inc | |||||||||||||
Full Title: A Phase 2, Randomized, Open-Label, 12-Week Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of GLM101 Administered Intravenously to Adult Participa... | |||||||||||||
Medical condition: PMM2-CDG | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002562-42 | Sponsor Protocol Number: TRCA-301E | Start Date*: 2017-12-15 | |||||||||||
Sponsor Name:Tricida, Inc. | |||||||||||||
Full Title: A Blinded, Placebo-Controlled Extension to Study TRCA-301 to Evaluate the Long-term Safety and Durability of Effect of TRC101 in Subjects with Chronic Kidney Disease and Metabolic Acidosis | |||||||||||||
Medical condition: Metabolic acidosis associated with Chronic Kidney Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) HU (Completed) SI (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003533-16 | Sponsor Protocol Number: UMCN-ONCO-201303 | Start Date*: 2013-11-21 |
Sponsor Name:Radboud University Nijmegen Medical Centre | ||
Full Title: Individualizing Pazopanib therapy by exploRing the role of Early metabolic responsE and drug exposure as a preDICTor for treatment outcome in patients with STS | ||
Medical condition: soft tissue sarcoma patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001550-34 | Sponsor Protocol Number: TIGEM2-PDH | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:FONDAZIONE TELETHON | |||||||||||||||||||||||||||||||||
Full Title: Studio clinico pilota per valutare l’efficacia della terapia con fenilbutirrato in pazienti affetti da deficit di piruvato deidrogenasi | |||||||||||||||||||||||||||||||||
Medical condition: La Sperimentazione verrà eseguita su pazienti affetti da difetto dell’enzima piruvato deidrogenasi.I pazienti affetti da questa malattia manifestano aumento dei livelli di lattato nel sangue e nell... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002852-33 | Sponsor Protocol Number: TOR-RIS-2004-01 | Start Date*: 2005-04-13 | |||||||||||
Sponsor Name:Dr. Jose Vicente Torregrosa Prats (fundacio clinic) | |||||||||||||
Full Title: a randomised, open clinical trial to study the efficacy of risedronate 35 mg/week in prevention of bone mass loss and vascular calcifications after kidney transplantation Ensayo aleatorio, abierto ... | |||||||||||||
Medical condition: bone metabolic pathology associated to kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003825-41 | Sponsor Protocol Number: TRCA-301 | Start Date*: 2017-09-21 | |||||||||||
Sponsor Name:Tricida, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects with Chronic Kidney Disease and Metabolic Acidosis | |||||||||||||
Medical condition: Metabolic acidosis associated with Chronic Kidney Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) SI (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000677-77 | Sponsor Protocol Number: S61338 | Start Date*: 2018-06-26 |
Sponsor Name:University Hospital Leuven | ||
Full Title: Novel strategies in weight loss in women with polycystic ovary syndrome: does the gut microbiome play a role? | ||
Medical condition: overweight and obese women with polycystic ovary syndrome (PCOS) at risk for metabolic syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003101-53 | Sponsor Protocol Number: ARTinMMS | Start Date*: 2007-01-10 | |||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||
Full Title: A randomised placebo controlled study of transdermal testosterone therapy (testosterone 1% hydroalcohol gel) to investigate the efficacy and safety in men with abdominal obesity, low testosterone l... | |||||||||||||
Medical condition: The metabolic syndrome constitutes a cluster of risk factors for cardiovascular disease with increased morbidity and mortality. The metabolic syndrome is referred to as a concomitant occurrence of ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002037-38 | Sponsor Protocol Number: NL44415.078.13 | Start Date*: 2013-10-29 |
Sponsor Name: | ||
Full Title: The effect of correction of metabolic acidosis in chronics kidney disease on intrarenal RAS activity. | ||
Medical condition: Metabolic acidosis in chronic kidney disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002222-23 | Sponsor Protocol Number: P170932J | Start Date*: 2019-02-05 |
Sponsor Name:APHP | ||
Full Title: Cobimetinib for BRAF-wild-type histiocytoses : a randomized, placebo-controlled, double blind study | ||
Medical condition: Histiocytoses are rare multisystemic disorders characterized by accumulation of histiocytes in various organs. patients with BRAF-wild type. | ||
Disease: | ||
Population Age: | Gender: | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022308-34 | Sponsor Protocol Number: JW/IB/AG | Start Date*: 2011-04-19 | ||||||||||||||||
Sponsor Name:Central Manchester Foundation Hospitals Trust | ||||||||||||||||||
Full Title: Eplerenone in Metabolic Syndrome: An investigation into the effects of Eplerenone on perivascular adipose tissue and small artery tone in obesity | ||||||||||||||||||
Medical condition: Obesity and Metabolic Syndrome (combination of obesity, hypertension, raised blood glucose and cholesterol abnormalities) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002815-20 | Sponsor Protocol Number: MET07 | Start Date*: 2007-10-09 | ||||||||||||||||
Sponsor Name:Royal Surrey County Hospital | ||||||||||||||||||
Full Title: A Prospective Randomised Pilot Study of Metformin and Lifestyle Intervention in the Prevention of Metabolic Syndrome due to Androgen Deprivation Therapy in Prostate Cancer | ||||||||||||||||||
Medical condition: Patients with prostate cancer on androgen deprivation therapy (ADT). Randomisation between standard treatment with ADT only, and the additional use of metformin with dietary and exercise advice. Ai... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002095-10 | Sponsor Protocol Number: MV-2-2017 | Start Date*: 2017-09-13 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Universitetsklinik for Nyresygdomme og Blodtryksforhøjelse, Regionshospitalet Holstebro; Hospitalsenheden Vest | ||||||||||||||||||||||||||||||||||||||
Full Title: Investigate the differences between treating Chronic Kidney Disease - Mineral and Bone Disorder with an iron-containing phosphate binder or a calcium-containing phosphate binder in Chronic Kidney D... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), especially bone metabolism and blood vessel calcification | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-004846-25 | Sponsor Protocol Number: Pfizer-Prevenar13-2015 | Start Date*: 2016-07-15 |
Sponsor Name:Maastricht University | ||
Full Title: Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders | ||
Medical condition: Familial hypercholesterolemia Niemann-Pick disease type B (NPB) Niemann-Pick disease type C (NPC) Partial lipodystrophy in children and adults | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-017051-10 | Sponsor Protocol Number: 09-313 | Start Date*: 2010-07-13 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Metabolic adverse events before and after glucocorticoid pulse therapy in rheumatoid arthritis | |||||||||||||
Medical condition: Patients with rheumatoid arthritis, who suffer from a exacerbation of disease can be included in this study. Exacerbation is defined as a Disease Activity Score of 5.1 or higher. Patients will be e... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003430-85 | Sponsor Protocol Number: OBERAL | Start Date*: 2017-11-29 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: A randomized, open, parallel design study to evaluate the effect on liver fat, adipose tissue and metabolic parameters when switching a protease inhibitor or efavirenz to once daily raltegravir in ... | ||
Medical condition: Study subjects are HIV infected patients with BMI>25kg/m2 and who have at least one metabolic syndrome component or a fatty liver disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000619-42 | Sponsor Protocol Number: PI14/00638 | Start Date*: 2015-05-05 |
Sponsor Name:FIBICO | ||
Full Title: An open, Phase II, clinical trial to evaluate the effectiveness of decreased intestinal absorption of phosphorus in the progression of renal disease in patients with metabolic syndrome | ||
Medical condition: Chronic kidney disease and metabolic syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007276-41 | Sponsor Protocol Number: Ram_GEP_1 | Start Date*: 2008-05-13 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie | ||
Full Title: Gene expression profiling in skeletal muscle of healthy subjects treated with ramipril | ||
Medical condition: healthy young males | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020875-22 | Sponsor Protocol Number: MetSNS | Start Date*: 2010-08-20 | |||||||||||||||||||||
Sponsor Name:RUNMC | |||||||||||||||||||||||
Full Title: In vivo induction of heme oxygenase-1 (HO-1) in the metabolic syndrome (MetS). Influence of heme arginate (Normosang) infusion on heme oxygenase-1 activity, endothelial dysfunction, insulin resista... | |||||||||||||||||||||||
Medical condition: Subjects suffer from the metabolic syndrome. Effects of study medication on insulin resistance and vascular function will be studied respectively. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.